Drug recall · September 23, 2015
Hyaluronic Acid Sodium 28 mg/ml + Lidocaine HCl 3 mg/ml Injection recall
Why: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Hyaluronic Acid Sodium 28 mg/ml + Lidocaine HCl 3 mg/ml Injection, ml Syringe, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
- Lots / codes
All lots distributed between November 2014 and May 2015; 03042015@6, 6/2/2015; 03122015@80, 6/10/2015; 03262015@43, 6/24/2015
- Quantity
- 20 ml total
- Company
- The Compounding Pharmacy of America, Knoxville, TN
- Distribution
- Nationwide
- Initiated
- June 2, 2015 · Voluntary: Firm initiated
- Classified
- September 15, 2015
- Reported
- September 23, 2015
- Ended
- February 10, 2016
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.